Regencell stock slips in premarket after Friday’s 14% drop puts focus back on volatility
NEW YORK, December 29, 2025, 05:56 ET — Premarket Regencell Bioscience Holdings Limited shares fell 3.2% to $20.48 in premarket trading on Monday. ChartMill The Nasdaq-listed microcap ended the prior session down nearly 14% at $21.16, extending a streak of sharp swings. ChartMill The move matters now because investors have had little fresh company news to trade against. Regencell’s investor relations site shows its most recent press release was dated October 31. Regencell Bioscience – That October release said Regencell filed its annual report on Form 20-F — an annual filing used by foreign private issuers — for the fiscal
